HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olivier Roy Selected Research

OVA 323-339

11/2018Design, Synthesis, and Immunological Evaluation of a Multicomponent Construct Based on a Glycotripeptoid Core Comprising B and T Cell Epitopes and a Toll-like Receptor 7 Agonist That Elicits Potent Immune Responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olivier Roy Research Topics

Disease

3Neoplasms (Cancer)
11/2021 - 11/2018
2Inflammation (Inflammations)
10/2017 - 08/2008
1Autoimmune Diseases (Autoimmune Disease)
11/2018
1Brain Injuries (Brain Injury)
02/2014
1Brain Infarction
02/2014
1Hypoxia (Hypoxemia)
02/2014
1Infarction (Infarctions)
02/2014
1Ischemia
02/2014
1Acute Kidney Injury (Acute Renal Failure)
01/2013
1Paramyxoviridae Infections (Parainfluenza)
12/2008
1Bovine Mastitis
08/2008
1Pneumonic Pasteurellosis (Shipping Fever)
09/2002

Drug/Important Bio-Agent (IBA)

2VaccinesIBA
11/2018 - 12/2008
1OVA 323-339IBA
11/2018
1Peptide TIBA
11/2018
1Toll-Like Receptor 7IBA
11/2018
1EpitopesIBA
11/2018
1flunixinIBA
10/2017
1flunixin meglumine (Banamine)IBA
10/2017
1CarrageenanIBA
10/2017
1SolutionsIBA
10/2017
1Dinoprostone (PGE2)FDA Link
10/2017
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2014
1Succinic Acid (Succinate)IBA
02/2014
1Peptides (Polypeptides)IBA
01/2013
1DiureticsIBA
01/2013
1(4,4)- biphenylalanyl- threonyl- seryl- tyrosyl- glutamyl- alanyl- leucyl- lysyl- lysineIBA
01/2013
1EP4 Subtype Prostaglandin E ReceptorsIBA
01/2013
1danofloxacinIBA
08/2008
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2002
1Anti-Bacterial Agents (Antibiotics)IBA
09/2002

Therapy/Procedure

1Chemoprevention
11/2021
1Neoadjuvant Therapy
11/2020
1Culture Diffusion Chambers
10/2017